ASCEND BY NTHRYS
Research Abroad Products

NGS Project Topics

Browse all focused areas across all project categories under this field.

Showing 37–48 of 200 project topics
Microsatellite Instability and MSI Status Detection Service
A specialized NGS data analysis service that identifies MSI status and deficient mismatch repair from circulating tumor DNA for immunotherapy eligibility. Monetizes through high-margin per-test fees, institutional contracts, and bundled oncology biomarker panels sold to cancer centers.
NGS Oncology Liquid Biopsy Platform Development Click to view more details →
Pharmacogenomics Integration and Drug-Mutation Matching Engine
Software that integrates liquid biopsy mutation profiles with pharmacogenomic databases to recommend precision-matched therapies and dosing strategies. Generates B2B SaaS revenue through institutional licensing and pharmaceutical partnerships for clinical decision support integration.
NGS Oncology Liquid Biopsy Platform Development Click to view more details →
High-Sensitivity Minimal Residual Disease Monitoring Dashboard
A web-based clinical dashboard that tracks MRD status across cancer treatment cycles using ultra-sensitive ctDNA detection algorithms. Supports recurring subscription revenue from oncology clinics and enables integration with EHR systems for seamless clinical workflows.
NGS Oncology Liquid Biopsy Platform Development Click to view more details →
Genomic Biomarker Discovery and Commercialization Platform
An end-to-end software platform that identifies novel prognostic and predictive biomarkers from liquid biopsy cohorts and packages them as validated diagnostic tests. Monetizes through licensing validated biomarker assays, clinical validation services, and revenue sharing on commercialized companion diagnostics.
NGS Oncology Liquid Biopsy Platform Development Click to view more details →
Cloud-Native NGS Pipeline SaaS for Rare Disease Detection
A scalable, pay-per-use cloud platform that automates NGS data processing, variant calling, and interpretation for rare disease diagnosis without infrastructure investment. Generates recurring revenue through subscription tiers while reducing turnaround time from weeks to days for diagnostic labs.
NGS Rare Disease Diagnostic Platform Dev Click to view more details →
AI-Powered Variant Interpretation Engine for Rare Conditions
Machine learning software that prioritizes pathogenic variants in rare disease cases using integrated databases and clinical phenotype matching. Creates competitive advantage through faster, more accurate diagnoses enabling premium pricing and white-label licensing opportunities.
NGS Rare Disease Diagnostic Platform Dev Click to view more details →
Exome and Genome Sequencing Analysis Workflow Marketplace
A managed SaaS platform offering modular, pre-validated NGS analysis workflows with configurable parameters for different rare disease panels. Monetizes through workflow licensing, per-sample processing fees, and premium data integration services.
NGS Rare Disease Diagnostic Platform Dev Click to view more details →
Real-Time NGS Quality Control and Metrics Dashboard
Enterprise monitoring software that tracks sequencing quality metrics, coverage depth, and contamination in real-time across multiple NGS runs. Delivers value through operational efficiency, reduced failed samples, and compliance documentation reducing liability costs.
NGS Rare Disease Diagnostic Platform Dev Click to view more details →
Rare Disease Gene Panel Design and Curation Platform
A commercial tool enabling clinical labs to design, validate, and maintain custom gene panels optimized for specific rare disease populations. Generates revenue through panel licensing, annual curation updates, and per-test royalties from partner labs.
NGS Rare Disease Diagnostic Platform Dev Click to view more details →
NGS Data Harmonization and Secondary Analysis Service
A managed service that standardizes raw NGS data from multiple sequencer platforms and performs comprehensive secondary analysis including copy number variation detection. Creates recurring B2B revenue while improving diagnostic yield and reducing computational burden on clinical partners.
NGS Rare Disease Diagnostic Platform Dev Click to view more details →
Regulatory-Compliant Rare Disease Report Generation Software
Automated reporting system generating CLIA-compliant, evidence-based clinical reports for rare disease diagnoses with integrated literature citations and variant classification. Enables premium pricing through reduced manual work, faster report turnaround, and reduced regulatory risk.
NGS Rare Disease Diagnostic Platform Dev Click to view more details →
Phenotype-Driven NGS Case Matching and Cohort Discovery
A platform that matches patient phenotypes to molecular findings and identifies similar cases across diagnostic networks for rare disease confirmation. Delivers value through improved diagnostic accuracy, research collaboration opportunities, and potential licensing fees from biotech partners.
NGS Rare Disease Diagnostic Platform Dev Click to view more details →